Different patterns of nicotinic acetylcholine receptor subunit transcription in human thymus

被引:15
作者
Bruno, R
Sabater, L
Tolosa, E
Sospedra, M
Ferrer-Francesch, X
Coll, J
Foz, M
Melms, A
Pujol-Borrell, R
机构
[1] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, LIRAD, CTBT,Dept Cell Biol Physiol & Immunol, Barcelona, Spain
[2] Univ Clin Tubingen, Tubingen, Germany
[3] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Div Neurol, Barcelona, Spain
[4] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Div Internal Med, Barcelona, Spain
关键词
myasthenia gravis; acetylcholine receptor; thymus; messenger RNA; RT-PCR;
D O I
10.1016/j.jneuroim.2003.11.022
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Clinical observations suggest that the thymus is strongly implicated in the pathogenesis of myasthenia gravis (MG), but questions such as the level and location of nicotinic acetylcholine receptor (AChR) subunit expression that are fundamental to postulate any pathogenic mechanism, remain controversial. We have re-examined this question by combining calibrated RT-PCR and real-time PCR to study nicotinic AChR subunit mRNA expression in a panel of normal and myasthenic thymi. The results suggest that the expression of the different AChR subunits follows three distinct patterns: constitutive for epsilon, neonatal for gamma and individually variable for alpha1, beta1 and delta. Experiments using confocal laser microdissection suggest that AChR is mainly expressed in the medullary compartment of the thymus but there is not a clear compartmentalization of subunit expression. The different patterns of subunit expression may influence decisively the level of central tolerance to the subunits and explain the focusing of the T cell response to the alpha and gamma subunits. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:147 / 159
页数:13
相关论文
共 55 条
[1]   THE HUMAN MUSCLE NICOTINIC ACETYLCHOLINE-RECEPTOR ALPHA-SUBUNIT EXISTS AS 2 ISOFORMS - A NOVEL EXON [J].
BEESON, D ;
MORRIS, A ;
VINCENT, A ;
NEWSOMDAVIS, J .
EMBO JOURNAL, 1990, 9 (07) :2101-2106
[2]  
Bruno R, 2002, EUR J IMMUNOL, V32, P2737, DOI 10.1002/1521-4141(2002010)32:10<2737::AID-IMMU2737>3.0.CO
[3]  
2-0
[4]   VALUE OF THYMECTOMY IN MYASTHENIA-GRAVIS - COMPUTER-ASSISTED MATCHED STUDY [J].
BUCKINGHAM, JM ;
HOWARD, FM ;
BERNATZ, PE ;
PAYNE, WS ;
HARRISON, EG ;
OBRIEN, PC ;
WEILAND, LH .
ANNALS OF SURGERY, 1976, 184 (04) :453-458
[5]   ILLEGITIMATE TRANSCRIPTION - TRANSCRIPTION OF ANY GENE IN ANY CELL TYPE [J].
CHELLY, J ;
CONCORDET, JP ;
KAPLAN, JC ;
KAHN, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (08) :2617-2621
[6]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[7]  
Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723
[8]   INVOLVEMENT OF HUMAN MUSCLE ACETYLCHOLINE-RECEPTOR ALPHA-SUBUNIT GENE (CHRNA) IN SUSCEPTIBILITY TO MYASTHENIA-GRAVIS [J].
GARCHON, HJ ;
DJABIRI, F ;
VIARD, JP ;
GAJDOS, P ;
BACH, JF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) :4668-4672
[9]  
Geuder K I, 1992, Dev Immunol, V2, P69, DOI 10.1155/1992/40576
[10]   Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology [J].
Gronseth, GS ;
Barohn, RJ .
NEUROLOGY, 2000, 55 (01) :7-15